NO20054646L - Doseringskur for ikke-steroidalt anti-inflammatorisk legemiddel - Google Patents

Doseringskur for ikke-steroidalt anti-inflammatorisk legemiddel

Info

Publication number
NO20054646L
NO20054646L NO20054646A NO20054646A NO20054646L NO 20054646 L NO20054646 L NO 20054646L NO 20054646 A NO20054646 A NO 20054646A NO 20054646 A NO20054646 A NO 20054646A NO 20054646 L NO20054646 L NO 20054646L
Authority
NO
Norway
Prior art keywords
steroidal anti
inflammatory drug
dosage course
dosage
course
Prior art date
Application number
NO20054646A
Other languages
English (en)
Norwegian (no)
Inventor
Gerard P Mcnally
Cathy K Gelotte
Douglas R Hough
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of NO20054646L publication Critical patent/NO20054646L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO20054646A 2003-03-21 2005-10-10 Doseringskur for ikke-steroidalt anti-inflammatorisk legemiddel NO20054646L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/008846 WO2004093864A1 (fr) 2003-03-21 2003-03-21 Regime posologique pour anti-inflammatoires non steroidiens

Publications (1)

Publication Number Publication Date
NO20054646L true NO20054646L (no) 2005-10-10

Family

ID=33308979

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054646A NO20054646L (no) 2003-03-21 2005-10-10 Doseringskur for ikke-steroidalt anti-inflammatorisk legemiddel

Country Status (10)

Country Link
EP (1) EP1605929B1 (fr)
JP (1) JP2006514982A (fr)
KR (1) KR101113005B1 (fr)
CN (1) CN1758904A (fr)
AU (2) AU2003220467A1 (fr)
BR (1) BR0318201A (fr)
CA (2) CA2746531C (fr)
MX (1) MXPA05010010A (fr)
NO (1) NO20054646L (fr)
WO (1) WO2004093864A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2190418T3 (pl) 2007-08-15 2014-03-31 Mcneil Ppc Inc Sposób dawkowania ibuprofenu o natychmiastowym i długotrwałym uwalnianiu
US9119878B2 (en) 2010-07-08 2015-09-01 Wellesley Pharmaceuticals, Llc Extended-release formulation for reducing the frequency of urination and method of use thereof
RS59258B1 (sr) * 2010-11-04 2019-10-31 Aft Pharmaceuticals Ltd Kombinovana kompozicija
EP2827852A4 (fr) * 2012-03-19 2016-03-02 Wellesley Pharmaceuticals Llc Formulation à libération prolongée pour réduire la fréquence de miction et son procédé d'utilisation
US10596127B2 (en) 2013-03-14 2020-03-24 Wellesley Pharmaceuticals, Llc Composition for reducing the frequency of urination, method of making and use thereof
WO2017039833A1 (fr) * 2015-09-01 2017-03-09 Wellesley Pharmaceuticals, Llc Formulations à action retardée, leurs procédés de fabrication et d'utilisation
KR20220113567A (ko) 2021-02-05 2022-08-16 이광미 염증 질환의 개선용 조성물
KR20240044914A (ko) 2022-09-29 2024-04-05 이광미 금속 티오옥토일 히알루로네이트 복합체를 포함하는 염증 질환의 개선용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2998450A (en) 1958-05-19 1961-08-29 Warner Lambert Pharmaceutical Process of preparing nu-acetyl-p-amino phenol
GB1497044A (en) 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
US4873231A (en) 1986-04-08 1989-10-10 Smith Walton J Decreasing the toxicity of an ibuprofen salt
CA2061520C (fr) 1991-03-27 2003-04-22 Lawrence J. Daher Systeme de delivrance accelerant l'effet et accroissant la puissance
IT1264855B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
IT1276689B1 (it) 1995-06-09 1997-11-03 Applied Pharma Res Forma farmaceutica solida ad uso orale

Also Published As

Publication number Publication date
JP2006514982A (ja) 2006-05-18
KR101113005B1 (ko) 2012-02-24
KR20060005345A (ko) 2006-01-17
AU2010202751A1 (en) 2010-07-22
WO2004093864A1 (fr) 2004-11-04
CA2519772C (fr) 2016-05-31
EP1605929B1 (fr) 2014-04-23
CN1758904A (zh) 2006-04-12
BR0318201A (pt) 2006-03-21
AU2003220467A1 (en) 2004-11-19
MXPA05010010A (es) 2006-03-10
CA2746531C (fr) 2016-06-28
CA2519772A1 (fr) 2004-11-04
CA2746531A1 (fr) 2004-11-04
EP1605929A1 (fr) 2005-12-21

Similar Documents

Publication Publication Date Title
NO20054646L (no) Doseringskur for ikke-steroidalt anti-inflammatorisk legemiddel
NO20062450L (no) Analgesiske suspensjoner med kontrollert frigivelse
MX2009013574A (es) Formas de dosificacion solidas o semisolidas de liberacion modificada.
MX2009005339A (es) Suspensiones analgesicas de liberacion modificada.
EA200501849A1 (ru) Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ
DK1519724T3 (da) Fredericamycin-derivater som lægemidler til behandling af tumorer
WO2007078874A3 (fr) Formulations pharmaceutiques à usage oral contenant des médicaments anti-inflammatoires non stéroïdiens et des inhibiteurs d'acides
TR200002786T2 (tr) Meloksikam için yeni galenik bir formülasyon.
WO2004071400A3 (fr) Inhibiteurs d'histone desacetylase de nouveaux derives de benzamide a differenciation puissante et a activite inhibant la proliferation
CY1109229T1 (el) Χρηση σπογγοσινης (2-μεθοξυαδενοσινης) για τη θεραπεια πονου, συγκεκριμενα υπερευαισθησιας στο πονο
EA200301200A1 (ru) Проникающая через кожу композиция селективного ингибитора циклооксигеназы-2
CY1108823T1 (el) Παραγωγα 2-υδροξυ-3-ετεροαρυλινδολης ως αναστολεις της gsk3
NO20055891L (no) Kinazolinderivater som aurorakinaseinhibitorer
WO2007075554A3 (fr) Traitement combine avec une composition d’inhibiteur de proteine kinase heterobicyclique a noyau 6,6-bicyclique et d'agents anticancereux
EA200970595A1 (ru) Производные замещенных индазолов, активные в качестве ингибиторов киназ
RU2006109467A (ru) Способы лечения рака с использованием ингибиторов hdac
BRPI0418029B8 (pt) formulação farmacêutica líquida, estável, adequada para administração parentérica que compreende um anticorpo agonista de cd40
NO20050060L (no) Medikament for behandling av overaktiv blaere
NO20055173L (no) Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel
MXPA06011467A (es) Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid).
NO20074109L (no) Intravenose formuleringer av PDE-5 inhibitorer
NO20062442L (no) Analgesiske suspensjoner md kontrollert frigivelse
GB0222514D0 (en) Organic compounds
DK1678162T3 (da) P-glycoprotein-inhibitor, fremgangsmåde til fremstilling heraf og farmaceutisk sammensætning omfattende denne
HUP0402577A2 (hu) Citoszol foszfolipáz A2 inhibitor hatású indolszármazékok, eljárás előállításukra

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application